Pharmaceuticals Roche announced Monday that the home test for COVID-19 has been approved by Canadian health authorities.
The SARS-CoV-2 Antigenic Nasal Self-Test allows you to test yourself using a nasal swab and obtain reliable results in 15 minutes for symptomatic or non-symptomatic patients.
The rapid test is an alternative for people at risk who can perform frequent tests without having to see a health professional, as health facilities are increasingly busy.
The test results were measured in three clinical studies and demonstrated a relative sensitivity of 94.9% to 100% in all three cases, the Laval-based company said.
“The approval of this home test is an important step forward in Canada’s response to the COVID-19 pandemic, as testing remains crucial to preventing its spread,” Peter Geimer, National Director of Health Care, said in a statement. , delocalized biology, at Roche Diagnostics.
“This test provides an additional tool to current screening methods already in place and makes it easier to test in places where laboratory instruments are not available and where rapid results are needed, such as long-term care institutions, educational institutions such as universities and other gathering places, ”explained Michele D’Elia, senior director, medical and scientific affairs at Roche Diagnostics.